Status:

UNKNOWN

A Clinical Trail of Acupuncture and Liu-Zi-Jue Exercise for Dysphagia in Post-stroke

Lead Sponsor:

The Third Affiliated hospital of Zhejiang Chinese Medical University

Conditions:

Stroke

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

The traditional Chinese medicine rehabilitation for post-stroke dysphagia impairment will be intervened, which can promote the recovery of dysphagia function of stroke patients, reduce the disability ...

Detailed Description

This study will collect inpatients from April 2020 to December 2022 who from the third affiliated hospital of Zhejiang university of traditional Chinese medicine, Jiaxing hospital of traditional Chine...

Eligibility Criteria

Inclusion

  • Dysphagia
  • Meet the diagnostic criteria of stroke in traditional Chinese medicine;
  • Meet the diagnostic criteria of ischemic stroke in western medicine;
  • meet the diagnostic criteria of pseudobulbar palsy;
  • Age is 18-85, gender not limited;
  • The course of disease is 30 to 180 days;
  • Water test level 3 and level 3 above;
  • Meet the requirements for indications of acupuncture and moxibustion techniques; Volunteer to participate in this project, the patient has no serious complications, can accept acupuncture treatment and good compliance;
  • Sign informed consent
  • MOCA(Montreal Cognitive Assessment) score above 15.

Exclusion

  • Dysphagia
  • Patients with true bulbar palsy caused by brainstem encephalitis, motor neurone disease, pontine tumor, multiple sclerosis, myasthenia gravis, medulla bulbar cavity;
  • Cerebral hemorrhage caused by cerebrovascular malformation, trauma, aneurysm and other causes;
  • Pregnant or lactating women;
  • Patients with severe primary chronic diseases, severe dementia and cognitive impairment, serious language understanding disorders, and mental illness, including heart, liver, kidney and other viscera, as well as the endocrine system and hematopoietic system;
  • Suffered from a variety of bleeding tendency diseases;
  • The patient to swallow contrast drug allergy;
  • Patients who do not meet the inclusion criteria, do not have poor treatment compliance as prescribed, cannot judge the efficacy or incomplete data affect the judgment of efficacy and are not suitable for clinical observation;

Key Trial Info

Start Date :

December 25 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2023

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT04398355

Start Date

December 25 2021

End Date

December 31 2023

Last Update

April 4 2022

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

The Third Affiliated Hospital of Zhejiang Chinese Medical University

Hangzhou, Zhejiang, China, 310000

2

Hangzhou hospital of traditional Chinese medicine

Hangzhou, Zhejiang, China, 310002

3

Jiaxing hospital of Chinese traditional medicine

Jiaxing, Zhejiang, China, 314000